Mutated 5,10-methylenetetrahydrofolate reductase, hyperhomocysteinemia and risk for cardiovascular disease. Nature, nurture or nonsense?
Blom
H J
HJ
Department of Pediatrics, University Medical Center Nijmegen, Nijmegen, The Netherlands. h.blom@ckslkn.azn.nl
D045103:5,10-Methylenetetrahydrofolate Reductase (FADH2); D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000235:genetics*; D020022:Genetic Predisposition to Disease; D006801:Humans; D020138:Hyperhomocysteinemia / Q000453:epidemiology / Q000235:genetics*; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D010088:Oxidoreductases / Q000235:genetics*; D017354:Point Mutation; D012307:Risk Factors
D010088:Oxidoreductases; D045103:5,10-Methylenetetrahydrofolate Reductase (FADH2); D042965:Methylenetetrahydrofolate Reductase (NADPH2)